Table 2.
Model 1: Age-adjusted model | Model 2: Previous use of antidepressants (additive model) | Model 3: Interaction model | ||||||||
---|---|---|---|---|---|---|---|---|---|---|
n | Events | PYRS | HR | 95% CI | HR | 95% CI | HR | 95% CI | ||
Cancer-free men | 357,384 | 1239 | 3,084,849 | 1.00 | Reference | 1.00 | Reference | |||
Prostate cancer | 37,527 | 108 | 237,638 | 1.05 | (0.85–1.26) | 1.02 | (0.84–1.25) | |||
Age at diagnosis, per year | 1.05 | (1.04–1.06) | 1.05 | (1.04–1.06) | ||||||
No previous use of antidepressants | 358,696 | 1134 | 3,069,137 | 1.00 | Reference | |||||
Previous use of antidepressants | 36,215 | 213 | 253,351 | 2.24 | (1.93–2.59) | |||||
Cancer-free men with previous depression | 32,402 | 187 | 231,889 | 1.00 | Reference | p = 0.1* | ||||
Prostate cancer patients with previous depression | 3813 | 26 | 21,462 | 1.39 | (0.92–2.10) | |||||
Cancer-free men without previous depression | 324,982 | 1052 | 2,852,960 | 0.44 | (0.34–0.57) | |||||
Prostate cancer patients without previous depression | 33,714 | 82 | 216,177 | 0.47 | (0.40–0.54) |
p-value of analysis of variance between the additive model (Model 2) and the interaction model (Model 3).